Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Adalimumab
Humira
Not routinely available
SMC (824/12)
12/11/2012
Indication
Treatment of moderately active Crohn's disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.
Therapeutic Area
Gastro-intestinal system
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
-
Comments
None
Link to Advice
Advice Published
12/11/2012
SMC Submission Type
Non submission
SMC Status
Not recommended